Clinical features of obstructive sleep apnea in children with obesity

Ai-Liang Liu1, Yue-Jie Zheng1, Zhe Su

  • 1Department of Respiratory Medicine, Shenzhen Children's Hospital, Shenzhen, Guangdong 518026, China (Yang Q, Email: 6468633@qq. com).

Insights

Obese children with obstructive sleep apnea (OSA) commonly experience daytime inattention and nighttime snoring. While sleep structure is similar to non-obese OSA patients, obese children show more severe respiratory events and oxygen desaturation.

Area of Science:

  • Pediatric Pulmonology
  • Sleep Medicine
  • Obesity Research

Background:

  • Obstructive sleep apnea (OSA) is a prevalent condition in children, often associated with obesity.
  • Understanding the clinical manifestations and polysomnographic features of OSA in obese children is crucial for effective management.

Purpose of the Study:

  • To investigate the clinical characteristics of obstructive sleep apnea (OSA) in obese children.
  • To compare polysomnographic findings between obese children with OSA and normal-weight children with OSA.

Main Methods:

  • Retrospective analysis of medical data from 33 obese children (7-15 years) diagnosed with OSA.
  • Comparison with 50 age- and sex-matched normal-weight children diagnosed with OSA, using polysomnography (PSG) data.

Main Results:

  • Daytime symptoms in obese OSA children included inattention (91%), somnolence (67%), and morning fatigue (64%). Nocturnal symptoms were snoring (82%), mouth breathing (61%), and sweating (49%).
  • Obese OSA children exhibited significantly higher apnea-hypopnea index, obstructive apnea/hypopnea index, and oxygen desaturation index compared to normal-weight OSA controls.
  • Both groups showed altered sleep structure (prolonged light sleep, shortened deep and REM sleep), with no significant inter-group differences in sleep architecture.

Conclusions:

  • Obese children with OSA present with distinct daytime and nocturnal symptoms, notably inattention and snoring.
  • Despite similar sleep structure alterations, obese children with OSA experience more severe respiratory disturbances and oxygen desaturation during sleep compared to their normal-weight counterparts.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
242
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
721
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.9K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
24